Manke Isaac
Insider CIK 1622769 · ADXN Director · OKUR Director · QTTB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 50,000 | — | $0 | 0 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award | 2026-09-02 | 2026-09-04 | 219,561 | — | $0 | 219,561 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer | 2026-09-02 | 2026-09-04 | 219,561 | — | $0 | 0 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 50,000 | — | $0 | 0 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award | 2026-09-02 | 2026-09-04 | 219,561 | — | $0 | 219,561 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer | 2026-09-02 | 2026-09-04 | 219,561 | — | $0 | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 15,300 | — | $0 | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 15,300 | — | $0 | 15,300 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 15,300 | — | — | 15,300 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 15,300 | — | — | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| QTTB Q32 Bio Inc. | M Exercise deriv | 2026-06-30 | 2026-07-02 | 53,521 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | M Exercise | 2026-06-30 | 2026-07-02 | 53,521 | $2.80 | $149.9K | 53,521 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2026-06-12 | 2026-07-21 | 10,826 | — | $0 | 10,826 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2026-06-12 | 2026-06-16 | 9,810 | — | $0 | 9,810 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award | 2025-12-31 | 2026-01-02 | 5,258 | — | $0 | 20,583 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-10-23 | 2025-10-27 | 53,521 | — | $0 | 53,521 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award | 2025-09-30 | 2025-10-02 | 5,545 | — | $0 | 15,325 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award | 2025-06-30 | 2025-07-02 | 6,311 | — | $0 | 9,780 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 7,650 | — | $0 | 7,650 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award | 2025-03-31 | 2025-04-02 | 3,469 | — | $0 | 3,469 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-27 | 12,767 | — | $0 | 12,767 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-27 | 19,008 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-27 | 2,627 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-27 | 19,008 | — | $0 | 19,008 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-27 | 12,767 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-27 | 2,627 | — | $0 | 2,627 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-01-15 | 2025-02-27 | 19,008 | — | $0 | 19,008 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 15,300 | — | $0 | 15,300 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2024-04-01 | 2024-09-30 | 2,627 | $13.42 | $35.3K | 2,627 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2024-03-25 | 2024-03-27 | 12,767 | — | $0 | 12,767 | SEC↗ |